Delivery Order SPE2DB22D1202-SPE2DB25FVLJ6
- Not listed
- The Defense Logistics Agency awarded a $10,028.45 firm fixed price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 9, 2025, with completion expected by September 10, 2025. This non-set-aside contract represents a pharmaceutical supply delivery under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,129.70 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's broader relationship with the federal government. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of the...
- The Defense Logistics Agency awarded a $17,870.71 delivery order to AmerisourceBergen Drug Corp for Bridion 500 mg/5 ml vials on August 27, 2025, with completion targeted for August 28, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,651.78 to AmerisourceBergen Drug Corp for Bridion 500 mg/5 mL vials on September 11, 2025, with completion scheduled for September 12, 2025. This competitive delivery order utilizes firm fixed pricing and is performed at the contractor's headquarters in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, valued at $13,599.02 under firm fixed price terms. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 500 mg/5 mL vials valued at $3,070.80, with an ultimate completion date of August 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $9,392.29 to AmerisourceBergen Drug Corp for Bridion 500 mg/5 mL vials (5 mL quantity) on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $19,114.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, with an ultimate completion date of August 4, 2025. This non-set-aside award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania, supporting federal medical procurement needs within...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Bridion 200 mg/2 mL vials totaling $2,544.38 with a completion date of August 26, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,947.02 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials. The contract, awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, is structured as a firm fixed price delivery order with no set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLJ6Delivery Order
The Defense Logistics Agency (DLA) awarded a $10,065.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 15, 2025, with an ultimate completion date of September 16, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems, making it a critical vendor in the Defense Health Agency's pharmaceutical supply chain. This delivery order represents a routine pharmaceutical procurement from AmerisourceBergen's comprehensive portfolio of brand-name and generic medications supplied to support military healthcare programs worldwide. The company's extensive federal contract history demonstrates consistent capability in fulfilling competitive medical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. As a prime vendor under the DLA's pharmaceutical support framework, AmerisourceBergen facilitates efficient procurement of essential medical commodities to support Defense Department healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 9/15/25 |